Introduction and objective:
Antimicrobial resistance, which is considered one of the most important problems of the 21 st century, brings many problems with it, such as increasing mortality rates and treatment costs. Difficulties in the treatment of infections caused by resistant microorganisms have led to the search and need for new antimicrobials or new molecules that interact synergistically with antimicrobials. The aim of this study is to investigate whether various flavonoids have synergistic effects with some antibiotics.

Material and methods:
During this study, standard bacterial strains Escherichia coli ATCC 25922, Klebsiella pneumoniae ATCC 700603, Pseudomonas aeruginosa ATCC 9027, Staphylococcus aureus ATCC 29213 and Staphylococcus aureus ATCC 43300 were used. Minimal inhibitory concentrations of all antibiotics and flavonoids were found by the broth microdilution method. Interactions between antibiotics and flavonoids were then determined by using the checkerboard method. Interactions between antibiotics and flavonoids were evaluated according to the FIC index (ΣFIC) results.

According to the results of the microdilution test, the bacterial strains used in this study (except for MRSA) were generally sensitive to antibiotics. Interaction study results showed promising results regarding the synergistic interactions of antibiotics with flavonoids. Epigallocatechin gallate and luteolin especially showed synergistic interaction with antibiotics in many microorganisms. It was found that myricetin showed synergistic interaction only with levofloxacin. Likewise, it was detected that apigenin had limited synergistic interaction with antibiotics.

The obtained results highlight that flavonoids may be a useful tool in overcoming antibiotic resistance.

Roca I, Akova M, Baquero F, et al. The global threat of antimicrobial resistance: science for intervention. New Microbes New Infect. 2015;16:22–9.
Spellberg B, Guidos R, Gilbert D, et al. The epidemic of antibiotic-resistant infections: A call to action for the medical community from the infectious diseases society of America. Clin Infect Dis. 2008;46:155–64.
Vural Keles D, Karatas S, Guven O. Health& Science II. In: Yucetas SC, editor. Covid-19 and bacterial infections. 1st ed. Istanbul: Efe Academy Publishing; 2022. p. 63–9.
Murray CL, Ikuta KS, Sharara F, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399:629–55.
WHO 2022. World Antibiotic Awareness Week [Online]. (accessed, October 2022).
Stepanović S, Antić N, Dakić I, et al. In vitro antimicrobial activity of propolis and synergism between propolis and antimicrobial drugs. Microbiol Res. 2003;158:353–7.
Aljeldah MM. Antimicrobial resistance and its spread is a global threat. Antibiotics. 2022;11;1082.
Buchmann D, Schultze N, Borchardt J, et al. Synergistic antimicrobial activities of epigallocatechin gallate, myricetin, daidzein, gallic acid, epicatechin, 3-hydroxy-6- methoxyflavone and genistein combined with antibiotics against ESKAPE pathogens. J Appl Microbiol. 2022;132:949–63.
van Vuuren S, Viljoen A. Plant-based antimicrobial studies--methods and approaches to study the interaction between natural products. Planta Med. 2011;77:1168–82.
Cottarel G, Wierzbowski J. Combination drugs, an emerging option for antibacterial therapy. Trends Biotechnol. 2007;12:547–55.
Betoni JEC, Passarelli Mantovani R, Nunes Barbosa L, et al. Synergism between plant extract and antimicrobial drugs used on Staphylococcus aureus diseases. Mem Inst Oswaldo Cruz. 2006;101:387–90.
Mundy L, Pendry B, Rahman M. Antimicrobial resistance and synergy in herbal medicine. J Herb Med. 2016;6:53–8.
Morimoto Y, Baba T, Sasaki T, et al. Apigenin asananti-quinolone-resistance antibiotic. Int J Antimicrob Agents. 2015;46:666–73.
Hu ZQ, Zhao WH, Hara Y, et al. Epigallocatechin gallate synergy with ampicillin/sulbactam against 28 clinical isolates of methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother. 2001;48:361–4.
Biharee A, Sharma A, Kumar A, et al. Antimicrobial flavonoids as a potential substitute for overcoming antimicrobial resistance. Fitoterapia. 2020;146:104720.
Yuan G, Guan Y, Yi H, et al. Antibacterial activity and mechanism of plant flavonoids to gram-positive bacteria predicted from their lipophilicities. Sci Rep. 2021;18:10471.
Hofer U. The cost of antimicrobial resistance. Nat Rev Microbiol. 2019;17:3–15.
Laishram S, Pragasam AK, Bakthavatchalam YD, et al. An update on technical, interpretative and clinical relevance of antimicrobial synergy testing methodologies. Indian J Med Microbiol. 2017;35:445–68.
Turk Dagi H, Kus H, Arslan U, et al. In vitro synergistic activity of sulbactam in combination with imipenem, meropenem and cefoperazone against carbapenem-resistant Acinetobacter baumannii isolates. Mikrobiyol Bul. 2014;48:311–5.
Wen W, Alseekh S, Fernie AR. Conservation and diversification of flavonoid metabolism in the plant kingdom. Curr Opin Plant Biol. 2020;55:100–8.
Sefton AM. Mechanisms of antimicrobial resistance: their clinical relevance in the new millennium. Drugs. 2002;62:557–66.
Cha SM, Kim GU, Cha JD. Synergistic antimicrobial activity of apigenin against oral pathogens. Int J Eng Res Sci. 2016;2:27–37.
Eumkeb G, Chukrathok S. Synergistic activity and mechanism of action of ceftazidime and apigenin combination against ceftazidime-resistant Enterobacter cloacae. Phytomedicine. 2013;20:262–9.
Das S, Tanwar J, Hameed S, et al. Antimicrobial potential of epigallocatechin-3- gallate (EGCG): a green tea polyphenol. J Biochem Pharmacol Res. 2014;2:167–74.
Ong KC, Khoo HE. Biological effects of myricetin. Gen Pharmacol. 1997;29:121–6.
Lin RD, Chin YP, Lee MH. Antimicrobial activity of antibiotics in combination with natural flavonoids against clinical extended-spectrum beta-lactamase (ESBL)-producing Klebsiella pneumoniae. Phytother Res. 2005;19:612–7.
Guo Y, Liu Y, Zhang Z, et al. The antibacterial activity and mechanism of action of luteolin against Trueperella pyogenes. Infect Drug Resist. 2020;13:1697–711.
Joung DK, Kang OH, Seo YS, et al. Luteolin potentiates the effects of aminoglycoside and β-lactam antibiotics against methicillin-resistant Staphylococcus aureus in vitro. Exp Ther Med. 2016;11:2597–601.